[Immunosuppressive therapy].
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002908:Chronic Disease; D003882:Dermatomyositis / Q000188:drug therapy; D004899:Erythroblastosis, Fetal / Q000517:prevention & control; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006402:Hematologic Diseases / Q000188:drug therapy; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000139:chemically induced; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011247:Pregnancy; D011658:Pulmonary Fibrosis / Q000139:chemically induced
D007166:Immunosuppressive Agents
Immunosuppressive Therapie